Advertisement
Brinkman joins Piper Jaffray as a managing director in the health caregroup, focusing on biopharmaceutical companies. He has extensive experience inpublic and private financings, and in advising companies on mergers andacquisitions. Previously, he was a managing director and head of biotechnologyinvestment banking at CIBC World Markets.
Advertisement
"Michael is an extremely talented banker who brings extensive experienceas a lead advisor in the biopharmaceutical sector," said Jon Salveson, head ofinvestment banking at Piper Jaffray. "For 25 years, we have been steady andcommitted to the business of health care. Adding an energized and seasonedprofessional like Michael to our leading health care platform is an extensionof that long-term commitment of Piper Jaffray -- a commitment which ourclients have come to expect."
Brinkman earned a bachelor's degree from the University of Witwatersrandin South Africa and completed his fellowship at the Faculty of Actuaries inEdinburgh, Scotland.
*Source: Dealogic and Piper Jaffray ECM; includes deals greater than $20million in deal size
About Piper Jaffray
Piper Jaffray Companies is a leading, international middle-marketinvestment bank and institutional securities firm, serving the needs ofmiddle-market corporations, private equity groups, public entities, nonprofitclients and institutional investors. Founded in 1895, Piper Jaffray provides acomprehensive set of products and services, including equity and debt capitalmarkets products; public finance services; mergers and acquisitions advisoryservices; high-yield and structured products; institutional equity andfixed-income sales and trading; and equity and high-yield research. Withheadquarters in Minneapolis, Piper Jaffray has 25 offices across the UnitedStates and international locations in London, Hong Kong, Shanghai and Beijing.Piper Jaffray & Co. is the firm's principal operating subsidiary. (NYSE: PJC)(http://www.piperjaffray.com)
Since 1895. Member SIPC and FINRA.
SOURCE Piper Jaffray
